Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer
Clinical trial NCT02817113 · TERMINATED
Trial details
- NCT number
- NCT02817113
- Sponsor
- Orient Europharma Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-09-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.